[1] Lisi, F., Carfagna, P., Oliva, M. M., Rago, R., Lisi, R., Poverini, R., Manna, C., Vaquero, E., Caserta, D., Raparelli, V., Marci, R., & Moscarini, M. (2012). Pretreatment with myo-inositol in non-polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reproductive Biology and Endocrinology, 10(52), 1-7. http://www.rbej.com/content/10/1/52
 
[2] Kalra, B., Kalra, S., & Sharma, J. (2016). The inositols and polycystic ovary syndrome. Indian Journal of Ednocrinology and Metabolism, 20(5), 720-724. DOI: 10.4103/2230-8210.189231
https://pubmed.ncbi.nlm.nih.gov/27730087/


[3] Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and d-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology. DOI: http://dx.doi.org/10.1155/2016/3204083

[4] Sortino, M. A., Salomone, S., Carruba, M. O., & Drago, F. (2017). Polycystic ovary syndrome: insights into the therapeutic approach with inositols. Journal Frontiers in Pharmacology, 8(341), 1-13. DOI: 10.3389/fphar.2017.00341
https://www.frontiersin.org/articles/10.3389/fphar.2017.00341/full

[5] U.S National Library of Medicine. (2018, July 26). Spontaneous reproductive outcomes after oral inositol supplementation in infertile polycystic ovarian syndrome women. https://clinicaltrials.gov/ct2/show/NCT03598374
 
[6] Lagana, A.S., Rossetti, P., Buscema, M., La Vignera, S., Condorelli, R.A., Gullo, G., Granese, R., & Triolo, O. (2016). Metabolism and ovarian function in PCOS women: A therapeutic approach with inositols. International Journal of Endocrinology, 2016, 1-9. https://doi.org/10.1155/2016/6306410

[7] Pundir, J., Psaroudakis, D., Savnur, P., Bhide, P., Sabatini, L., Teede, H., Coomarasamy, A., & Thangaratinam, S. (2017). Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomized trials. An International Journal of Obstetrics and Gynaecoloy, 299-308. DOI: 10.1111/1471-0528.14754
https://pubmed.ncbi.nlm.nih.gov/29226510/

[8] Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and d-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology, 2016. https://doi.org/10.1155/2016/3204083


[9] Bhide, P., Pundir, J., Gudi, A., Shah, A., Homburg, R., & Acharya, G. (2019). The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis. Obstetrics & Gynaecology, 98(10). https://doi.org/10.1111/aogs.13625

[10] 2018 Mar 2;34(2):/j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067.
Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature
https://pubmed.ncbi.nlm.nih.gov/29498933/
 
[11] Notaro ALG, Neto FTL. The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet. 2022;39(3):573–579. doi: 10.1007/s10815-022-02429-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list] 
https://pubmed.ncbi.nlm.nih.gov/35156149/

[12] Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M, et al. Inositols: From Established Knowledge to Novel Approaches. Int J Mol Sci. 2021;22(19):10575. doi: 10.3390/ijms221910575. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
https://pubmed.ncbi.nlm.nih.gov/34638926/

[13] Fariba Seyedoshohadaei 1 2, Shahin Abbasi 1, Masoumeh Rezaie 1 2, Azra Allahvaisi 2 3, Mohammad Jafar Rezaie 2 3, Nasrin Soufizadeh 1, Khaled Rahmani 4. Myo-inositol effect on pregnancy outcomes in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: A double-blind RCT. Int J Reprod Biomed
. 2022 Sep 6;20(8):643-650. doi: 10.18502/ijrm.v20i8.11753. eCollection 2022 Aug.
Affiliations expand
https://pubmed.ncbi.nlm.nih.gov/36313255/

[14] Vittorio Unfer, Simona Dinicola, and Michele Russo. A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes? Published online 2023 Mar 25. doi: 10.3390/ijms24076213. Int J Mol Sci. 2023 Apr; 24(7): 6213.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094056/

[14] Iñaki Lete 1, Ainara Martínez 1, Irene Lasaga 1, Eva Centurión 1, Amaia Vesga 1. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. Review Gynecol Endocrinol. 2024 Dec;40(1):2301554. doi:10.1080/09513590.2023.2301554. Epub 2024 Jan 18.
https://pubmed.ncbi.nlm.nih.gov/38239032/

[15]Mariano Bizzarri 1 2, Noemi Monti 1, Aurora Piombarolo 1, Antonio Angeloni 1, Roberto Verna 2 Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. Affiliations expand
PMID: 37111094 PMCID: PMC10145676 DOI:10.3390/nu150818753
https://pubmed.ncbi.nlm.nih.gov/37111094/

[16] Costanzo Moretti 1, Marco Bonomi 2 3, Paola Dionese 4, Silvia Federici 2 3, Anna Maria Fulghesu 5, Jacopo Giannelli 6, Roberta Giordano 7, Laura Guccione 1, Elisa Maseroli 8, Paolo Moghetti 9, Roberto Mioni 10, Rosario Pivonello 11, Chiara Sabbadin 12, Carla Scaroni 12, Massimo Tonacchera 13, Nunzia Verde 14, Linda Vignozzi 8, Alessandra Gambineri 15. Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women’s Endocrinology. Endocrinology
PMID: 39009925 DOI: 10.1007/s40618-024-02363-w
https://pubmed.ncbi.nlm.nih.gov/39009925/